Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii.
El Bissati K, Chentoufi AA, Krishack PA, Zhou Y, Woods S, Dubey JP, Vang L, Lykins J, Broderick KE, Mui E, Suzuki Y, Sa Q, Bi S, Cardona N, Verma SK, Fraczek L, Reardon CA, Sidney J, Alexander J, Sette A, Vedvick T, Fox C, Guderian JA, Reed S, Roberts CW, McLeod R. El Bissati K, et al. Among authors: vedvick t. JCI Insight. 2016 Sep 22;1(15):e85955. doi: 10.1172/jci.insight.85955. JCI Insight. 2016. PMID: 27699241 Free PMC article.
Optimized subunit vaccine protects against experimental leishmaniasis.
Bertholet S, Goto Y, Carter L, Bhatia A, Howard RF, Carter D, Coler RN, Vedvick TS, Reed SG. Bertholet S, et al. Vaccine. 2009 Nov 23;27(50):7036-45. doi: 10.1016/j.vaccine.2009.09.066. Epub 2009 Sep 26. Vaccine. 2009. PMID: 19786136 Free PMC article.
In vitro evaluation of TLR4 agonist activity: formulation effects.
Misquith A, Fung HW, Dowling QM, Guderian JA, Vedvick TS, Fox CB. Misquith A, et al. Colloids Surf B Biointerfaces. 2014 Jan 1;113:312-9. doi: 10.1016/j.colsurfb.2013.09.006. Epub 2013 Sep 19. Colloids Surf B Biointerfaces. 2014. PMID: 24121074 Free PMC article.
A synthetic adjuvant to enhance and expand immune responses to influenza vaccines.
Coler RN, Baldwin SL, Shaverdian N, Bertholet S, Reed SJ, Raman VS, Lu X, DeVos J, Hancock K, Katz JM, Vedvick TS, Duthie MS, Clegg CH, Van Hoeven N, Reed SG. Coler RN, et al. PLoS One. 2010 Oct 27;5(10):e13677. doi: 10.1371/journal.pone.0013677. PLoS One. 2010. PMID: 21060869 Free PMC article.
92 results